UCFA
AIFF

United Capital Financial Advisors’s Firefly Neuroscience AIFF Stock Holding History

United Capital Financial Advisors’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-667
Closed -$19K – 1119
2022
Q3 		$19K Hold
667
– – ﹤0.01% 1073
2022
Q2 		$27K Buy
667
+334
+100% +$32.2K ﹤0.01% 1105
2022
Q1 		$53K Hold
333
– – ﹤0.01% 1139
2021
Q4 		$50K Buy
+333
New +$39.8K ﹤0.01% 1184

Other funds holding AIFF

LI
Lafayette Investments Ashton, Maryland $494M AUM 11.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

United Capital Financial Advisors's AIFF Position: Q4 2022 in Review

United Capital Financial Advisors sold out of Firefly Neuroscience (AIFF) in Q4 2022, closing a stake of 667 shares — an estimated $19K sold.

United Capital Financial Advisors first reported a position in AIFF in Q4 2021 and held it in 4 quarters. The position peaked at $53K in Q1 2022. 17 funds tracked by Wall St. Rank hold AIFF as of Q4 2022.

  • United Capital Financial Advisors reported no remaining Firefly Neuroscience position as of Q4 2022 after selling out during the quarter.
  • United Capital Financial Advisors sold 667 Firefly Neuroscience shares in Q4 2022, an estimated $19K.
  • United Capital Financial Advisors first reported a position in Firefly Neuroscience in Q4 2021 and held it in 4 quarters.
  • United Capital Financial Advisors's Firefly Neuroscience position peaked at $53K in Q1 2022.
  • 17 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q4 2022.

Based on United Capital Financial Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.